This culminates in an extremely high accumulation in PSMA-expressing prostate cancer cells in vitro and tissue in vivo (tumors, spleen, and in the case of DP1-PSMAt derivatives, kidneys). The gene discussed is FOLH1; the disease is prostate carcinoma.